Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FP404
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,439
Award facts
- Contract value 100% obligated
- $21,439.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,439.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, with an ultimate completion date of January 8, 2026. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order represents a task call against the prime pharmaceutical distribution contract that authorizes AmerisourceBergen to supply a comprehensive range of pharmaceutical products, generic and brand-name medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which serves as the place of performance for this contract—is a major pharmaceutical distributor and critical vendor for federal medical procurement. The company operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the prime IDC with DLA. Through this delivery order structure, the company continues to fulfill essential pharmaceutical supply needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The firm fixed-price delivery order model provides DLA with flexibility in requesting specific pharmaceutical products and medical supplies as operational needs arise within the established contract ceiling and terms.
Quick answers
Who was awarded contract SPE2DU26FP404?
SPE2DU26FP404 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DU26FP404 worth?
The government has obligated $21,439 on SPE2DU26FP404.
Is contract SPE2DU26FP404 an order under another contract?
Yes. SPE2DU26FP404 is a delivery order under SPE2DU25D5141, an indefinite delivery contract.
Was contract SPE2DU26FP404 competed?
The extent of competition for SPE2DU26FP404 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award